Masks are required inside all of our care facilities. We are vaccinating all eligible patients. Learn more:
Vaccines, Boosters & Additional Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus
Find more COVID-19 testing locations on Maryland.gov.
The Neurocognition Program studies complex neural systems and behaviors — including touch perception, motor control, social behaviors, reward, mood and decision-making — to inform the development of therapeutics for nervous system disorders ranging from autism to addiction.
The Neurodegeneration Program studies the fundamental causes of neurodegenerative disorders — including Alzheimer’s disease, amyotrophic lateral sclerosis, Huntington’s disease and Parkinson’s disease — with a mission to develop interventions to mitigate and cure them.
Johns Hopkins Drug Discovery works with researchers across the university to discover and develop tomorrow’s therapeutics for a wide range of human disorders.
The International Arts + Mind Lab is a multidisciplinary research-to-practice initiative that is accelerating the field of neuroaesthetics. Its mission is to amplify human potential by addressing intractable problems in health, well-being and learning using the arts.
Launched in 2007, the Brain Science Institute unified the tremendous thought leadership across the Johns Hopkins community in the brain sciences and related disciplines. To date, over 50 schools, departments, divisions, centers and institutes participate in this multidisciplinary umbrella organization, the largest and most diverse group in the university.